Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Novel optic nerve-regenerating growth factor identified as potential glaucoma therapeutic

Nov. 27, 2001

New product significantly reduces the risk of AMD

Nov. 26, 2001

Alcon identifies several related series of antiglaucoma agents

Nov. 22, 2001

Positive opinion issued for Lumigan by CPMP

Nov. 21, 2001

Launch of Xalcom/Xalacom begins in Europe

Nov. 20, 2001

Six-month results presented for CAT-152 following glaucoma and cataract surgery

Nov. 16, 2001

Oculex commences phase II trial of Posurdex for PME

Oct. 30, 2001

Bausch & Lomb acquires loteprednol etabonate line

Oct. 15, 2001

Asahi Glass describes novel antiglaucoma difluoroprostaglandins

Oct. 11, 2001

Indian research institute evaluates andrographolide derivatives

Sep. 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026